Grand Junction, CO1 Active Studies

Parkinsons Disease Clinical Trials in Grand Junction, CO

Find 1 actively recruiting parkinsons disease clinical trials in Grand Junction, CO. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
1,500
Enrolling

Recruiting Parkinsons Disease Studies in Grand Junction

About Parkinsons Disease Clinical Trials in Grand Junction

Parkinson's disease is a progressive nervous system disorder that affects movement, causing tremors, stiffness, and difficulty with balance. It results from the loss of dopamine-producing neurons in the brain. Treatment includes medications, deep brain stimulation, and emerging therapies targeting disease modification.

There are currently 1 parkinsons disease clinical trials recruiting participants in Grand Junction, CO. These studies are seeking a combined 1,500 participants. Research is being sponsored by Boston Scientific Corporation. Clinical trial participation is free and participants receive study-related medical care at no cost.

Parkinsons Disease Clinical Trials in Grand Junction — FAQ

Are there parkinsons disease clinical trials in Grand Junction?

Yes, there are 1 parkinsons disease clinical trials currently recruiting in Grand Junction, CO. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Grand Junction?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Grand Junction research site will contact you about next steps.

Are clinical trials in Grand Junction free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Grand Junction studies also compensate for your time and travel.

What parkinsons disease treatments are being tested?

The 1 active trials in Grand Junction are testing new therapies including novel drugs, biologics, and treatment approaches for parkinsons disease.

Data updated July 13, 2026 from ClinicalTrials.gov